- Home
- FULC vs HBT Comparison
FULC vs HBT Comparison
Compare FULC & HBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FULC | HBT |
|---|---|---|
| Founded | 2015 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 718.4M | 904.3M |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FULC | HBT |
|---|---|---|
| Price | $7.50 | $26.55 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | $16.38 | ★ $28.63 |
| AVG Volume (30 Days) | ★ 1.1M | 64.6K |
| Earning Date | 01-01-0001 | 04-27-2026 |
| Dividend Yield | N/A | ★ 3.50% |
| EPS Growth | N/A | ★ 7.96 |
| EPS | N/A | ★ 2.44 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $29.69 |
| Revenue Next Year | N/A | $11.55 |
| P/E Ratio | ★ N/A | $10.79 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.32 | $19.46 |
| 52 Week High | $15.74 | $29.88 |
Technical Indicators
Market Signals| Indicator | FULC | HBT |
|---|---|---|
| Relative Strength Index (RSI) | 32.44 | 40.38 |
| Support Level | $7.40 | $24.39 |
| Resistance Level | $7.64 | $26.81 |
| Average True Range (ATR) | 0.64 | 0.76 |
| MACD | -0.10 | -0.19 |
| Stochastic Oscillator | 1.00 | 34.87 |
Price Performance
Historical ComparisonAbout FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About HBT HBT Financial Inc.
HBT Financial Inc provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses, and municipal entities throughout Central and Northeastern Illinois and Eastern Iowa. It operates through one reportable segment: community banking.